Cellular Metabolic Heterogeneity and Therapeutic Targeting in Rheumatoid Arthritis
Cells · 26.10.2026 · 15 (21) · 1949
DOI: 10.3390/cells15211949 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 26.10.2026. Verfasst von Sheng Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid. Die Arbeit nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Metabolic abnormalities in rheumatoid arthritis (RA) differ across cell populations and anatomical compartments. Glycolytic synovial fibroblasts coexist with blood T-cell populations showing impaired glycolytic induction or mitochondrial function, while macrophage metabolism can sustain inflammation or tissue protection. These differences complicate systemic metabolic inhibition. This narrative review integrates human RA studies, experimental arthritis and mechanistic work in other systems to identify dependencies that support defined pathogenic functions. We examine metabolite transport, nutrient adaptation and nutrient and energy sensing, distinguishing causal perturbation from descriptive signatures and preclinical hypotheses from clinical efficacy signals. Systemic cardiometabolic disease and nutritional interventions provide a clinical context for interpreting local metabolic findings. Small trials of repurposed drugs suggest possible benefit during treatment, but do not establish durable metabolic correction. We propose that a claim of reprogramming requires persistent functional change after drug removal, exclusion of residual exposure and selective cell loss, and preservation of immune regulation and host defence. These criteria could guide more selective metabolic interventions and their evaluation in patient tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Stem Cell Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan 430030, China.
ORCID-Profile: Sheng Chen
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Chen, S., Luo, Y., Zhou, Q., & Chen, H. (2026). Cellular Metabolic Heterogeneity and Therapeutic Targeting in Rheumatoid Arthritis. Cells, 15(21), 1949. https://doi.org/10.3390/cells15211949
Vancouver
Chen S, Luo Y, Zhou Q, Chen H. Cellular Metabolic Heterogeneity and Therapeutic Targeting in Rheumatoid Arthritis. Cells. 2026;15(21):1949. doi:10.3390/cells15211949
BibTeX
@article{Chen2026,
author = {Chen, Sheng and Luo, Yufan and Zhou, Qiuzhi and Chen, Hong},
title = {Cellular Metabolic Heterogeneity and Therapeutic Targeting in Rheumatoid Arthritis},
journal = {Cells},
year = {2026},
volume = {15},
number = {21},
pages = {1949},
doi = {10.3390/cells15211949}
}
EUVIMED